Navigation Links
New weapon against highly resistant microbes within grasp

An active compound from fungi and lower animals may well be suitable as an effective weapon against dangerous bacteria. We're talking about plectasin, a small protein molecule that can even destroy highly resistant bacteria . Researchers at the Universities of Bonn, Utrecht, Aalborg and of the Danish company Novozymes AS have shed light on how the substance does this. The authors see plectasin as a promising lead compound for new antibiotics.

These results will be published in Science journal on 28th May.

More and more bacteria are becoming resistant to normal antibiotics. This is especially true for the methicillin-resistant Staphylococcus aureus (MRSA). Most of the pharmaceutical weapons are now useless against these MRSA strains . According to estimates, as many as every second patient in the USA treated by intensive-care medicine comes down with an MRSA infection.

Plectasin could shift the balance of power back in the doctors' favour. But how exactly does the little protein molecule do that? The Bonn researchers in Dr. Tanja Schneider and Professor Hans-Georg Sahl's team have answered these questions together with Danish and Dutch colleagues. Thus plectasin disrupts the forming of the cell wall in bacteria so that the pathogens can no longer divide.

Theft at the bacteria's construction site

In this process, plectasin behaves like a thief which steals the stones off a mason. 'It binds to a cell-wall building block called lipid II and thus prevents it from being incorporated ,' Professor Sahl explains. 'However, bacteria cannot live without a cell wall.' It comes as no surprise that the most famous antibiotic penicillin also inhibits cell-wall synthesis.

Yet plectasin is more similar in its mode of action to another widely used drug, vancomycin. Vancomycin had been the drug of choice in combating MRSA strains since the 1980s. Meanwhile, though, there are more and more bacteria that are also resistant to vancomycin. 'However, these strains are still susceptible to plectasin,' Dr. Tanja Schneider emphasises. Nevertheless, there is no permanent solution to the resistance problem even with a new antibiotic . 'It is always just a question of time until the pathogens mutate and become insensitive ,' she says. 'It's a never ending arms race.'

Plectasin belongs to the class of defensins. These defence molecules are widespread among fungi, animals and also plants. Humans, for example, produce defensins on their skin and in this way nip infections in the bud. 'Defensins not only kill pathogens but also alert the immune system', Dr. Hans-Henrik Kristensen from the Danish company Novozymes AS explains. 'So the pharmaceutical industry is setting its hopes on them.'


Contact: Dr. Hans-Georg Sahl
University of Bonn

Related medicine news :

1. The almond trees secret weapon
2. A Healthy Diet Remains Your Best Weapon Against the #1 Killer: Heart Disease
3. Stents May Be Effective Weapon Against Stroke
4. Keeping the Boston Bruins Healthy. Their New - Very Cold - Secret Weapon Against Injuries
5. Global Aids Alliance Celebrates the Introduction of the International Violence Against Women Act, Urges Swift Passage
6. More than 30 Percent of Seniors Are Not Immunized Against Pneumonia in 36 States; New Report Finds Low Adult Vaccination Rates in U.S.
7. More than 30 percent of seniors are not immunized against pneumonia in 36 states
8. Acupuncture found effective against depression during pregnancy
9. Tobacco Heir to Speak Out Against Tobacco at Saint Francis Hospital
10. Black Community Unites Against HIV/AIDS Epidemic
11. Luis Tiant and Sunridge International Partner to Provide Medical Relief in Cuba: Former Star Pitcher for the Red Sox and Yankees Leads the Fight Against Glaucoma
Post Your Comments:
(Date:12/1/2015)... ... 2015 , ... CloudLIMS today announced that it is the ... the New Products and Services category for its innovative product offering, BioTracer. ... that helps labs organize data and track samples with storage inventories. BioTracer's SaaS ...
(Date:12/1/2015)... ... December 01, 2015 , ... Diabetic foot ... States. Podiatrists are well aware that psychology-based patient non-compliance (disobedience of a health ... contributors to diseases of the diabetic foot. The American Board of Multiple ...
(Date:12/1/2015)... IL (PRWEB) , ... December 01, 2015 , ... ... keeping their independence is everything. That is why Hollister Incorporated has launched the ... to offer this next product in the VaPro touch free catheter portfolio,” said ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... has been selected as a finalist in this year’s Fierce Innovation Awards: Healthcare ... IT Healthcare was recognized as a finalist in the category of Digital Solutions ...
(Date:12/1/2015)... ... 2015 , ... TCS Healthcare Technologies (TCS), a leading provider ... is pleased to announce that VIP Care Services, a Caprock Health Group affiliate ... Complete Care™ Management to back their collaborative catastrophic case management initiatives. ACUITY Complete ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 2015 /PRNewswire/ -- Royal Philips  (NYSE: ... X-ray imaging software that produces high-contrast images for all ... a grid, at the 2015 Radiological Society of ... is Philips, first digital imaging solution providing grid-like contrast ... clinician,s workflow and supports "first-time-right imaging" by decreasing the ...
(Date:12/1/2015)... PUNE, India , December 1, 2015 ... new market research report "Immunotherapy Drugs Market by Type of ... Vaccines), Checkpoint Inhibitors), Epidemiology, Regulatory and Pipeline Analysis - Global ... Market is poised to reach USD 73,529.2 Million by 2020 ... 12.8% from 2015 to 2020. Browse ...
(Date:12/1/2015)... MASON, Ohio , Dec. 1, 2015 /PRNewswire/ ... enhancement to its GeneSight® Psychotropic test giving healthcare providers ... make medication decisions for patients suffering from depression, ... and other behavioral health conditions. ...   --> With the addition of ...
Breaking Medicine Technology: